Needham cut Apellis Pharmaceuticals, Inc. APLS price target from $85 to $60. Needham analyst Joseph Stringer maintained a Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback